Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Personalized High-Rate Fluid Removal Guided by Ultrasound in Hospitalized ESRD with Fluid Overload

Official title: FluId removaL With a High Rate ulTRAfiltration Protocol in paTiEnts With Intravascular Congestion: the FILTRATE Trial

Run by Universidad Autonoma de Nuevo Leon · NCT07705269 · Data updated 2026-11-12

This trial tests whether using ultrasound to guide a higher rate of fluid removal is as safe and effective as standard fluid removal for adults with end-stage kidney disease who are admitted for severe fluid overload.

More Fluid Overload trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorUniversidad Autonoma de Nuevo Leon
Academic / other
Locations1 site (Monterrey, Nuevo León)
StatusRecruiting
StartedJune 4, 2026
Main results expectedJune 2027
Study endsOctober 2027
Registry record updatedJuly 15, 2026
Trial IDNCT07705269 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with end-stage kidney disease on chronic hemodialysis admitted for acute fluid overload and ultrasound-confirmed severe intravascular congestion, who are hemodynamically stable.

Probably not a fit

Patients with low baseline blood pressure, shock, acute coronary syndrome, severe valvular disease, or other excluded conditions may not benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a personalized, ultrasound-guided high-rate ultrafiltration strategy to standard fluid removal in adults with end-stage renal disease requiring hospital-based fluid removal for acute congestion. Ultrasound techniques, including lung ultrasound and VExUS, are used to identify patients with severe intravascular congestion and guide treatment. The goal is to determine if rapid fluid removal can relieve symptoms without increasing risk compared with conventional rates. The study is conducted at a tertiary center in Monterrey, with collaboration between Universidad Autonoma de Nuevo Leon and Hospital Universitario Dr. Jose E. Gonzalez. Participants are adults on long-term hemodialysis, hemodynamically stable at baseline, and meeting ultrasound-confirmed congestion criteria.

Why it matters

Potential benefit: If successful, patients could experience quicker relief from congestion with a safe, personalized fluid removal approach.

How similar studies have gone: Previous practices often use higher ultrafiltration rates outside guidelines, but rigorous ultrasound-guided testing of this approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults over 18 years old with End-Stage Renal Disease on hemodialysis for at least 3 months.
* Admitted to the hospital requiring mechanical fluid removal for acute fluid overload (first in-hospital session).
* Clear ultrasound evidence of severe intravascular congestion (such as diffuse B-lines in the lungs or altered VExUS vascular flow patterns).
* Hemodynamically stable with a baseline blood pressure of at least 120/80 mmHg.

Exclusion Criteria:

* Baseline low blood pressure (\<100/60 mmHg) or active shock (cardiogenic, septic, or distributive).
* Acute coronary syndrome (heart attack), severe heart valve disease, or severe fluid around the heart.
* Known chronic lung disease.
* Pregnancy.

Where it's running

  • Hospital Universitario "Dr. José E. González"
    Monterrey, Nuevo León, Mexico
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.